Doctor profile · Federal record
Dr. Millicent Amankwah, M.D
Medical Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Des Moines, IA
- NPI 1881071223
- Accepts Medicare
- MIPS 81.7 / 100 · 2023
- 15 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1221 Pleasant St Ste 250
Des Moines, IA 503091423
(515) 241-4674
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- July 16, 2025
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (2)
- Iowa #54516 · Connecticut #12881256
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881071223. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
12
Distinct HCPCS
1
Medicare allowed
$2,053
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 12 | 12 | $171 |
In context: peer comparison
Among 6 peers in Des Moines Medical Oncology Physician, average services per provider: 1,267. This provider delivers 0.0× the peer median.Open Payments
Industry payments received
All-time total
$1,261
Transactions
51
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 5 | $168.02 | |
| Daiichi Sankyo INC. | 3 | $146.48 | |
| Novartis Pharmaceuticals Corporation | 8 | $131.37 | |
| Janssen Biotech, INC. | 6 | $109.31 | |
| Pfizer INC. | 6 | $107.85 | |
| GlaxoSmithKline, LLC. | 4 | $78.99 | |
| Abbvie INC. | 2 | $50.93 | |
| Merck Sharp & Dohme LLC | 2 | $50.02 | |
| Dendreon Pharmaceuticals LLC | 2 | $49.72 | |
| Astellas Pharma US INC | 3 | $48.27 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $35.55 | |
| Regeneron Healthcare Solutions, INC. | 2 | $35.39 | |
| Stemline Therapeutics INC. | 2 | $33.55 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $31.77 | |
| Alexion Pharmaceuticals, INC. | 2 | $30.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
233
Patients
90
Total drug cost
$4,364
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 52 | 37 | $1,077 |
| Ondansetron Odt (Ondansetron) | Brand | 34 | 21 | $700 |
| Oxycodone Hcl | Generic | 28 | 19 | $567 |
| Anastrozole | Generic | 24 | 0 | $582 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 22 | 13 | $494 |
| Letrozole | Generic | 20 | 0 | $335 |
| Olanzapine | Generic | 16 | 0 | $243 |
| Amlodipine Besylate | Generic | 14 | 0 | $136 |
| Promethazine Hcl | Generic | 12 | 0 | $81 |
| Dexamethasone | Generic | 11 | 0 | $149 |
Hospital affiliations
Frequently asked questions
What is Dr. Millicent Amankwah's medical specialty?
Dr. Millicent Amankwah practices Medical Oncology Physician in Des Moines, IA.
Where does Dr. Millicent Amankwah practice?
Dr. Millicent Amankwah practices at 1221 Pleasant St Ste 250, Des Moines, IA 503091423. Office phone: 5152414674.
What is Dr. Millicent Amankwah's NPI?
Dr. Millicent Amankwah's National Provider Identifier (NPI) is 1881071223, issued by NPPES.
Does Dr. Millicent Amankwah accept Medicare assignment?
Yes. Dr. Millicent Amankwah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Millicent Amankwah commonly perform?
Top Medicare-reported procedures in 2023: Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.